Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Tvardi Therapeutics Inc., 3 years.
Tvardi Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2025 | Seres Therapeutics Inc. | Open-market sale | −4,416 | $0.81 | $3,577 |
| Feb 15, 2025 | Seres Therapeutics Inc. | Option exercise | +2,969 | — | — |
| Feb 15, 2025 | Seres Therapeutics Inc. | Option exercise | +8,907 | — | — |
| Nov 18, 2024 | Seres Therapeutics Inc. | Open-market sale | −977 | $0.54 | $528 |
| Nov 15, 2024 | Seres Therapeutics Inc. | Option exercise | +2,969 | — | — |
| Oct 28, 2024 | Seres Therapeutics Inc. | Open-market sale | −4,334 | $0.69 | $2,990 |
| Oct 27, 2024 | Seres Therapeutics Inc. | Option exercise | +13,744 | — | — |
| Aug 16, 2024 | Seres Therapeutics Inc. | Open-market sale | −973 | $0.84 | $817 |
| Aug 15, 2024 | Seres Therapeutics Inc. | Option exercise | +2,969 | — | — |
| Jun 4, 2024 | Tvardi Therapeutics Inc. | Grant or award | +150,647 | — | — |
| May 15, 2024 | Seres Therapeutics Inc. | Option exercise | +2,968 | — | — |
| May 15, 2024 | Seres Therapeutics Inc. | Open-market sale | −939 | $0.94 | $883 |
| Feb 16, 2024 | Seres Therapeutics Inc. | Open-market sale | −4,400 | $1.08 | $4,752 |
| Feb 15, 2024 | Seres Therapeutics Inc. | Option exercise | +11,875 | — | — |
| Oct 30, 2023 | Seres Therapeutics Inc. | Open-market sale | −4,232 | $1.35 | $5,713 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.